Announced
Completed
Synopsis
Inflexion, a mid-market private equity firm, completed the acquisition of Sunovion Pharmaceuticals Europe, a provider of pharmaceutical drugs, from Sumitomo Dainippon Pharma, a pharmaceutical company based in Japan. Financial terms were not disclosed. "Sumitomo Dainippon Pharma Group will continue to pursue its global strategy, which focuses on direct sales in the markets of Japan, North America, and China and other Asian countries, while maximizing growth in collaboration with partners in Europe and other regions," Sumitomo Dainippon Pharma.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.